Ern Yu Tan Selected Research

Neoplasms (Cancer)

10/2022	Predicting the Likelihood of Carrying a BRCA1 or BRCA2 Mutation in Asian Patients With Breast Cancer.
9/2022	Relevance of the MHC region for breast cancer susceptibility in Asians.
5/2022	Impact of Subsidy on the Use of Personalized Medicine in Breast Cancer.
12/2021	Germline breast cancer susceptibility genes, tumor characteristics, and survival.
4/2021	Development of a microRNA Panel for Classification of Abnormal Mammograms for Breast Cancer.
11/2020	EZH2-mediated PP2A inactivation confers resistance to HER2-targeted breast cancer therapy.
1/2020	Impact of deviation from guideline recommended treatment on breast cancer survival in Asia.
11/2019	Recurrence of breast cancer after regional or general anaesthesia: a randomised controlled trial.
1/2018	Hypoxic tumor microenvironment activates GLI2 via HIF-1α and TGF-β2 to promote chemoresistance in colorectal cancer.
1/2018	GNA13 expression promotes drug resistance and tumor-initiating phenotypes in squamous cell cancers.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ern Yu Tan Research Topics

Disease

25	Breast Neoplasms (Breast Cancer) 10/2022 - 01/2007
19	Neoplasms (Cancer) 10/2022 - 01/2007
5	Neoplasm Metastasis (Metastasis) 08/2016 - 07/2013
4	Noninfiltrating Intraductal Carcinoma (DCIS) 09/2021 - 01/2007
3	Hypoxia (Hypoxemia) 01/2022 - 01/2007
3	Triple Negative Breast Neoplasms 01/2022 - 07/2013
3	Infections 01/2019 - 12/2014
2	Genetic Risk Score 05/2022 - 01/2022
1	Ovarian Neoplasms (Ovarian Cancer) 10/2022
1	Fever (Fevers) 05/2022
1	Neutropenia 05/2022
1	Febrile Neutropenia 05/2022
1	Granulomatous Mastitis 01/2021
1	Abscess 01/2021
1	Pain (Aches) 11/2019
1	Mastodynia 11/2019
1	Virus Diseases (Viral Diseases) 01/2019
1	Parkinson Disease (Parkinson's Disease) 01/2018
1	Colorectal Neoplasms (Colorectal Cancer) 01/2018
1	Tics (Tic) 01/2018
1	Dyskinesias (Dyskinesia) 01/2018
1	Pathologic Complete Response 01/2017
1	Dengue (Dengue Fever) 01/2017
1	Carcinogenesis 10/2016
1	Liver Neoplasms (Liver Cancer) 10/2016
1	Circulating Neoplastic Cells 08/2016
1	Wounds and Injuries (Trauma) 01/2014
1	Carcinoma (Carcinomatosis) 01/2007

Drug/Important Bio-Agent (IBA)

7	Biomarkers (Surrogate Marker)IBA 11/2021 - 08/2016
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2016
4	Estrogen ReceptorsIBA 01/2017 - 01/2007
3	Phenobarbital (Luminal)FDA Link 12/2021 - 12/2014
2	ChromatinIBA 01/2022 - 10/2016
2	MicroRNAs (MicroRNA)IBA 11/2021 - 04/2021
2	RNA (Ribonucleic Acid)IBA 01/2019 - 10/2016
2	ErbB Receptors (EGF Receptor)IBA 01/2017 - 07/2013
2	Paclitaxel (Taxol)FDA LinkGeneric 11/2015 - 10/2015
1	Tumor Biomarkers (Tumor Markers)IBA 10/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2022
1	ORALIT (ORS)IBA 09/2022
1	HLA Antigens (Human Leukocyte Antigens)IBA 09/2022
1	HLA-C Antigens (HLA-C)IBA 09/2022
1	Trastuzumab (Herceptin)FDA Link 05/2022
1	Circulating MicroRNAIBA 11/2021
1	Complement System Proteins (Complement)IBA 09/2021
1	Genetic Markers (Genetic Marker)IBA 01/2021
1	Immunoglobulin M (IgM)IBA 01/2021
1	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 11/2020
1	Propofol (Diprivan)FDA LinkGeneric 11/2019
1	Sevoflurane (Ultane)FDA LinkGeneric 11/2019
1	Opioid Analgesics (Opioids)IBA 11/2019
1	LigandsIBA 01/2019
1	InterferonsIBA 01/2019
1	Antiviral Agents (Antivirals)IBA 01/2019
1	Small Interfering RNA (siRNA)IBA 01/2019
1	Transcription Factors (Transcription Factor)IBA 01/2018
1	Levodopa (L Dopa)FDA LinkGeneric 01/2018
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2018
1	Pharmaceutical PreparationsIBA 01/2018
1	Capsules (Microcapsules)IBA 01/2018
1	Cell-Free Nucleic AcidsIBA 11/2017
1	11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA 11/2017
1	Phosphotransferases (Kinase)IBA 11/2017
1	Hormones (Hormone)IBA 01/2017
1	Tamoxifen FDA LinkGeneric 01/2017
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2017
1	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 01/2017
1	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2016
1	RNA Polymerase IIIIBA 10/2016
1	Transfer RNA (tRNA)IBA 10/2016
1	Superoxides (Superoxide)IBA 08/2016
1	Superoxide DismutaseIBA 08/2016
1	CaspasesIBA 08/2016
1	Free RadicalsIBA 08/2016
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2016
1	Interleukin-1 Receptor-Associated KinasesIBA 10/2015
1	ras GTPase-Activating Proteins (ras-GAP)IBA 12/2014
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 12/2014
1	ras ProteinsIBA 12/2014
1	UbiquitinIBA 07/2013
1	Protein Tyrosine PhosphatasesIBA 07/2013
1	Oxygen (Dioxygen)IBA 01/2007
1	Indicators and Reagents (Reagents)IBA 01/2007
1	Carbonic Anhydrase IXIBA 01/2007

Therapy/Procedure

8	Therapeutics 05/2022 - 07/2013
5	Drug Therapy (Chemotherapy) 05/2022 - 10/2014
1	Precision Medicine 05/2022
1	Immunotherapy 01/2022
1	Radiotherapy 01/2020
1	Analgesia 11/2019
1	Oral Administration 01/2018
1	Neoadjuvant Therapy 01/2017
1	Mastectomy (Mammectomy) 01/2015
1	Animal Assisted Therapy 09/2014
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 02/2014
1	Length of Stay 01/2014
1	Ambulatory Surgical Procedures (Outpatient Surgery) 01/2014